Mohamed Benderdour Selected Research

Mohamed Benderdour Research Topics

Disease

17	Osteoarthritis 03/2024 - 08/2004
16	Inflammation (Inflammations) 03/2024 - 03/2005
6	Arthritis (Polyarthritis) 12/2019 - 07/2008
5	Rheumatoid Arthritis 01/2018 - 07/2008
2	Fibrosis (Cirrhosis) 04/2013 - 10/2012
2	Necrosis 01/2011 - 01/2006
2	Osteoporosis 01/2011 - 08/2004
2	Ischemia 08/2010 - 10/2002
2	Hypertrophy 11/2004 - 11/2003
1	Hypersensitivity (Allergy) 12/2022
1	Multiple Abnormalities 10/2021
1	Hemolysis 01/2020
1	Bone Resorption 12/2019
1	Heart Diseases (Heart Disease) 10/2012
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2012
1	Anhedonia 11/2011
1	Infarction (Infarctions) 11/2011
1	Neoplasms (Cancer) 01/2011
1	Reperfusion Injury 08/2010
1	Myocardial Ischemia (Ischemic Heart Diseases) 08/2010
1	Contusions 03/2009
1	Spinal Cord Injuries (Spinal Cord Injury) 03/2009
1	Disease Progression 01/2007
1	Bone Diseases (Bone Disease) 03/2005
1	Cardiomegaly (Heart Hypertrophy) 11/2003

Drug/Important Bio-Agent (IBA)

6	4-hydroxy-2-nonenal (4-hydroxynonenal)IBA 08/2017 - 11/2003
5	Proteins (Proteins, Gene)FDA Link 10/2021 - 11/2004
5	EnzymesIBA 12/2019 - 11/2003
4	DNA (Deoxyribonucleic Acid)IBA 01/2012 - 07/2008
3	resolvin D1IBA 03/2024 - 08/2016
3	ProstaglandinsIBA 01/2023 - 01/2011
3	Prostaglandin D2IBA 12/2020 - 01/2017
3	LipocalinsIBA 12/2020 - 06/2013
3	prostaglandin R2 D-isomerase (prostaglandin D2 synthase)IBA 12/2020 - 06/2013
3	CytokinesIBA 01/2020 - 11/2011
3	Small Interfering RNA (siRNA)IBA 01/2020 - 01/2011
3	Folic Acid (Vitamin M)FDA LinkGeneric 01/2018 - 07/2008
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2018 - 01/2006
3	Dinoprostone (PGE2)FDA Link 05/2014 - 01/2006
3	ChitosanIBA 01/2012 - 07/2008
3	isocitrate dehydrogenase (NADP+)IBA 11/2004 - 10/2002
2	LipidsIBA 03/2024 - 12/2023
2	prostaglandin D2 receptorIBA 01/2023 - 01/2017
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2020 - 07/2012
2	CollagenIBA 12/2019 - 01/2018
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 06/2013 - 03/2012
2	Ramipril (Altace)FDA LinkGeneric 04/2013 - 10/2012
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2011 - 01/2011
2	Interleukin-1beta (Interleukin 1 beta)IBA 01/2011 - 01/2011
2	Interleukin-1 (Interleukin 1)IBA 07/2008 - 01/2007
2	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 03/2005 - 08/2004
1	AntioxidantsIBA 03/2024
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 03/2024
1	MetalsIBA 12/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2020
1	Durapatite (Hydroxylapatite)IBA 12/2019
1	Therapeutic UsesIBA 12/2019
1	Cathepsin KIBA 12/2019
1	monomethoxypolyethyleneglycol- cholesteryl esterIBA 01/2018
1	ProtandimIBA 01/2017
1	gingerolIBA 01/2017
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 08/2016
1	ImmunosorbentsIBA 08/2016
1	pentosidineIBA 09/2014
1	CarnosineIBA 09/2014
1	AldehydesIBA 09/2014
1	Hyaluronic Acid (Hyaluronan)IBA 08/2014
1	Sorbitol (Yal)FDA Link 08/2014
1	Prostaglandin-E SynthasesIBA 05/2014
1	Type 1 Angiotensin ReceptorIBA 10/2012
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 10/2012
1	salicylhydroxamic acid (SHAM)IBA 11/2011
1	Escitalopram FDA Link 11/2011
1	Sucrose (Saccharose)IBA 11/2011
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2011
1	thymoquinoneIBA 01/2011
1	Caspase 3 (Caspase-3)IBA 01/2011
1	Connexin 43 (Connexin43)IBA 08/2010
1	Peptides (Polypeptides)IBA 08/2010
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 03/2009
1	Atorvastatin (Lipitor)FDA Link 03/2009
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 07/2008
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 07/2008
1	PPAR gammaIBA 01/2007
1	Interleukin-6 (Interleukin 6)IBA 01/2006
1	Messenger RNA (mRNA)IBA 11/2004
1	Succinic Acid (Succinate)IBA 10/2002
1	Citric Acid (Citrate)FDA LinkGeneric 10/2002

Therapy/Procedure

2	Therapeutics 03/2024 - 01/2011
1	Knee Replacement Arthroplasty (Total Knee Replacement) 12/2022
1	Oral Administration 10/2012